Cryptotanshinone reverses the epithelial‐mesenchymal transformation process and attenuates bleomycin‐induced pulmonary fibrosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cryptotanshinone reverses the epithelial‐mesenchymal transformation process and attenuates bleomycin‐induced pulmonary fibrosis
Authors
Keywords
-
Journal
PHYTOTHERAPY RESEARCH
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-04-13
DOI
10.1002/ptr.6699
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma
- (2019) Shuo Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cryptotanshinone Attenuates Oxidative Stress and Inflammation through the Regulation of Nrf-2 and NF-κB in Mice with Unilateral Ureteral Obstruction
- (2018) Wei Wang et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Inhibition of mTOR ameliorates bleomycin-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition
- (2018) Qian Han et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer’s disease
- (2018) Francesco Maione et al. PHARMACOLOGICAL RESEARCH
- Nrf2 antioxidant pathway suppresses Numb-mediated epithelial–mesenchymal transition during pulmonary fibrosis
- (2018) Zhihui Zhang et al. Cell Death & Disease
- Cryptotanshinone hinders renal fibrosis and epithelial transdifferentiation in obstructive nephropathy by inhibiting TGF-β1/Smad3/integrin β1 signal
- (2018) Wei Wang et al. Oncotarget
- Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition
- (2018) Sun Young Kyung et al. BMC Pharmacology & Toxicology
- The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis
- (2018) Elena Bargagli et al. Internal and Emergency Medicine
- CCR2+ monocytic myeloid-derived suppressor cells (M-MDSCs) inhibit collagen degradation and promote lung fibrosis by producing transforming growth factor-β1
- (2017) Astrid Lebrun et al. JOURNAL OF PATHOLOGY
- Cryptotanshinone Inhibits STAT3 Signaling to Alleviate Cardiac Fibrosis in Type 1-like Diabetic Rats
- (2017) Shih-Hsiang Lo et al. PHYTOTHERAPY RESEARCH
- Role of epithelial-mesenchymal transition (EMT) and fibroblast function in cerium oxide nanoparticles-induced lung fibrosis
- (2017) Jane Ma et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Idiopathic pulmonary fibrosis
- (2017) Fernando J. Martinez et al. Nature Reviews Disease Primers
- Cryptotanshinone downregulates the profibrotic activities of hypertrophic scar fibroblasts and accelerates wound healing: A potential therapy for the reduction of skin scarring
- (2016) Yan Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Amplified canonical transforming growth factor-β signallingviaheat shock protein 90 in pulmonary fibrosis
- (2016) Zaneta Sibinska et al. EUROPEAN RESPIRATORY JOURNAL
- Tumor macrophages are pivotal constructors of tumor collagenous matrix
- (2016) Ran Afik et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
- (2016) Luca Richeldi et al. RESPIRATORY MEDICINE
- Epigallocatechin gallate attenuates fibroblast proliferation and excessive collagen production by effectively intervening TGF-β1 signalling
- (2015) Narayanan Sriram et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
- (2015) Paul W. Noble et al. EUROPEAN RESPIRATORY JOURNAL
- Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β–dependent epithelial to mesenchymal transition
- (2015) Haiying Tang et al. JOURNAL OF SURGICAL RESEARCH
- Cryptotanshinone, a novel tumor angiogenesis inhibitor, destabilizes tumor necrosis factor-α mRNA via decreasing nuclear-cytoplasmic translocation of RNA-binding protein HuR
- (2015) Zhijie Zhu et al. MOLECULAR CARCINOGENESIS
- Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis in rats
- (2015) HUANYU HE et al. Molecular Medicine Reports
- Total extract of Yupingfeng attenuates bleomycin-induced pulmonary fibrosis in rats
- (2015) Liucheng Li et al. PHYTOMEDICINE
- Tanshinone IIA Attenuates Bleomycin-Induced Pulmonary Fibrosis via Modulating Angiotensin-Converting Enzyme 2/ Angiotensin-(1-7) Axis in Rats
- (2014) Huajie Wu et al. International Journal of Medical Sciences
- Cryptotanshinone Attenuates Cardiac Fibrosis via Downregulation of COX-2, NOX-2, and NOX-4
- (2014) Yunzi Ma et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis
- (2013) Hillary Loomis-King et al. CURRENT OPINION IN PHARMACOLOGY
- Protective effect of cryptotanshinone on lipopolysaccharide-induced acute lung injury in mice
- (2013) Ying Tang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A New Antifibrotic Target of Ac-SDKP: Inhibition of Myofibroblast Differentiation in Rat Lung with Silicosis
- (2012) Hong Xu et al. PLoS One
- Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression
- (2012) Suzanne Ostrand-Rosenberg et al. SEMINARS IN CANCER BIOLOGY
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Cryptotanshinone Suppressed Inflammatory Cytokines Secretion in RAW264.7 Macrophages through Inhibition of the NF-κB and MAPK Signaling Pathways
- (2010) Shu Tang et al. INFLAMMATION
- STAT3 in tissue fibrosis: Is there a role in the lung?
- (2010) Darryl Knight et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started